ILAE Symposium: Redefining Treatment Resistant Epilepsy
Program Length: 90 minutes
Although the concept of refractory epilepsy may appear to beself-explanatory and intuitive at first glance, a precise definition hasremained elusive. This has resulted in diverse criteria being used by differentclinicians and researchers, making it difficult to compare results acrossstudies and to make recommendation for clinical practice. It is hoped that aconsensus definition proposed by the ILAE will have global impact in improvingpatient care and facilitating clinical research. This session will discuss thedifficulty in deriving the definition, will explain the new ILAE definition,and will outline future plans to use the definition.
- Assessresponse to therapy and assign a category of response to AED therapy (response,failure, inadequate trial)
- Determinetiming for referral of patients for non-medical therapies in refractorypatients
- Applyunderstanding of the new ILAE definition for treatment resistant epilepsy
- Definemedical intractability in children using the new ILAE definition applies tochildren with epilepsy.
Neurologists epileptologists, advanced practice nurses andneuropsychologists
Co-Chairs: Jacqueline A. French, M.D. and Samuel Wiebe, M.D.
Samuel Wiebe, M.D.
Complexities in Defining Treatment Resistance
Patrick Kwan, M.D., Ph.D.
ILAE Definition of Refractory Epilepsy
Anne T. Berg, Ph.D.
Consideration of Special Populations
Alexis A. Arzimanoglou, M.D.
The Future: Where Do We Go From Here?
Jacqueline A. French, M.D.